Views & Analysis | Perspectives on pharma industry issues

Digital

Tech & Trials: Can AI save us from drowning in data?

Data – it’s everywhere! Especially in clinical trials, where an average trial of about 2,000 patients can expect to produce 3,000,000 points of data.

Patients

Gilead's HIV success and controversy: Expanding access amid ...

Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly effective medicine.

R&D

The future of drug development: Integrating open source and ...

Clinical trials for drug development are becoming increasingly complex, with numerous variables that must be identified and defined from the start.

Digital

Sponsored

Hyntelo: AI solutions for improved customer engagement

Hyntelo, an AI solutions company, specialises in helping pharmaceutical companies leverage data for better customer engagement.

Patients

The power of patient insights in shaping successful drug dev...

The pharmaceutical industry is undergoing a major transformation, placing patients at the forefront of drug development like never before.

Sales & Marketing

Unlocking impact and growth at times of demerger

Pharma and medtech companies have undergone unprecedented growth through aggressive M&A over the

Digital

Sponsored

Creating True Value with GenAI

Pharma companies are moving their Generative AI (GenAI) investments from pilot to production through exploration, experimentation, industrialisation/scaling, adoption, and monetisation.

Digital

Sponsored

Seven pillars of GenAI for enterprise-level value generation

Today, we live in an age of artificial intelligence (AI); more specifically, the age of generative AI (GenAI).

Sales & Marketing

Unlocking impact and growth at times of demerger

Pharma and medtech companies have undergone unprecedented growth through aggressive M&A over the

Sales & Marketing

Optimising HCP engagement through a data-driven omnichannel ...

To encourage the uptake of complex therapies in clinical practice, brand teams must ensure they use data-driven insights to understand the needs and preferences of healthcare professionals

Digital

Tech & Trials: Can AI save us from drowning in data?

Data – it’s everywhere! Especially in clinical trials, where an average trial of about 2,000 patients can expect to produce 3,000,000 points of data.

Digital

Sponsored

Hyntelo: AI solutions for improved customer engagement

Hyntelo, an AI solutions company, specialises in helping pharmaceutical companies leverage data for better customer engagement.

Market Access

Updating of England’s budget impact test threshold

England has a lot of ways to put downward pressure on prices of new treatments and the budget impact test - prompting commercial discussions if a new treatment looks like it will cost more

Market Access

Medical start-ups must address the evolving risks of the FDA...

Embarking on the journey of a medical start-up is like navigating a complex labyrinth, where the final prize is the coveted FDA approval.

Oncology

Strategies for commercialising oncology treatments for young...

The oncology landscape is evolving, with a marked rise in cancer incidence among young adults globally.

Oncology

Beyond COVID-19: mRNA vaccines aim to revolutionise cancer c...

mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment.

Oncology

Dr Meredith McKean interview with Nicole Raleigh

ESMO 2024 – Dr Meredith McKean

In our final video from ESMO 2024, web editor Nicole Raleigh spoke with Dr Meredith McKean, a melanoma investigator at the Sarah Cannon Research Institute.